BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34213375)

  • 1. Toward a doxorubicin-loaded bioinspired bone cement for the localized treatment of osteosarcoma.
    Martinez T; Sarda S; Dupret-Bories A; Charvillat C; Projetti F; Drouet C
    Future Oncol; 2021 Sep; 17(26):3511-3528. PubMed ID: 34213375
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitumor effect of calcium phosphate cement incorporating doxorubicin microspheres].
    Zhang H; Xue ZL; Qi AM; Li S; Ye JD
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Feb; 30(2):278-83. PubMed ID: 20159700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma.
    Kamata E; Kawamoto T; Ueha T; Hara H; Fukase N; Minoda M; Morishita M; Takemori T; Fujiwara S; Nishida K; Kuroda R; Kurosaka M; Akisue T
    Anticancer Res; 2017 Nov; 37(11):6097-6106. PubMed ID: 29061790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of a biomaterial-based anticancer drug delivery system as an alternative to conventional post-surgery bone cancer treatment.
    Bischoff I; Tsaryk R; Chai F; Fürst R; Kirkpatrick CJ; Unger RE
    Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():115-124. PubMed ID: 30274043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteosarcoma cell death induced by innovative scaffolds doped with chemotherapeutics.
    Lanzillotti C; Iaquinta MR; De Pace R; Mosaico M; Patergnani S; Giorgi C; Tavoni M; Dapporto M; Sprio S; Tampieri A; Montesi M; Martini F; Mazzoni E
    J Cell Physiol; 2024 May; 239(5):e31256. PubMed ID: 38591855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
    Hu T; Fei Z; Su H; Xie R; Chen L
    Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional bone cement for synergistic magnetic hyperthermia ablation and chemotherapy of osteosarcoma.
    Liang B; Zuo D; Yu K; Cai X; Qiao B; Deng R; Yang J; Chu L; Deng Z; Zheng Y; Zuo G
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110460. PubMed ID: 31923975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
    Tan ML; Friedhuber AM; Dass CR
    J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of the antitumor effect of calcium phosphate cement containing anticancer drug and caffeine on rat osteosarcoma.
    Tanzawa Y; Tsuchiya H; Shirai T; Nishida H; Hayashi K; Takeuchi A; Kawahara M; Tomita K
    J Orthop Sci; 2011 Jan; 16(1):77-84. PubMed ID: 21360005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro delivery and controlled release of Doxorubicin for targeting osteosarcoma bone cancer.
    Kamba SA; Ismail M; Hussein-Al-Ali SH; Ibrahim TA; Zakaria ZA
    Molecules; 2013 Aug; 18(9):10580-98. PubMed ID: 23999729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
    Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
    Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model.
    Higuchi T; Yamamoto J; Sugisawa N; Tashiro Y; Nishino H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
    Cancer Genomics Proteomics; 2020; 17(1):35-40. PubMed ID: 31882549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of lipid composition on the ability of liposome loaded voacamine to improve the reversion of doxorubicin resistant osteosarcoma cells.
    Giansanti L; Condello M; Altieri B; Galantini L; Meschini S; Mancini G
    Chem Phys Lipids; 2019 Sep; 223():104781. PubMed ID: 31229409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts.
    Gazzano E; Buondonno I; Marengo A; Rolando B; Chegaev K; Kopecka J; Saponara S; Sorge M; Hattinger CM; Gasco A; Fruttero R; Brancaccio M; Serra M; Stella B; Fattal E; Arpicco S; Riganti C
    Cancer Lett; 2019 Aug; 456():29-39. PubMed ID: 31047947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.
    Xu M; Jin H; Xu CX; Sun B; Song ZG; Bi WZ; Wang Y
    Mol Ther; 2015 Jan; 23(1):89-98. PubMed ID: 25292190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment.
    Rong ZJ; Yang LJ; Cai BT; Zhu LX; Cao YL; Wu GF; Zhang ZJ
    J Mater Sci Mater Med; 2016 May; 27(5):89. PubMed ID: 26975746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC inhibitor-loaded bone cement for advanced local treatment of osteosarcoma and chondrosarcoma.
    Tonak M; Becker M; Graf C; Eckhard L; Theobald M; Rommens PM; Wehler TC; Proschek D
    Anticancer Res; 2014 Nov; 34(11):6459-66. PubMed ID: 25368246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An mTOR and VEGFR inhibitor combination arrests a doxorubicin resistant lung metastatic osteosarcoma in a PDOX mouse model.
    Oshiro H; Tome Y; Miyake K; Higuchi T; Sugisawa N; Kanaya F; Nishida K; Hoffman RM
    Sci Rep; 2021 Apr; 11(1):8583. PubMed ID: 33883561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.